DelveInsight’s "Neuroblastoma - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Neuroblastoma epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.
Markets Covered • United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan
Study Period: 2016-2027
Neuroblastoma Epidemiology The epidemiology section covers the historical, current as well as forecasted epidemiology for Neuroblastoma in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Neuroblastoma outlook. It also includes the explanation of changing trends of epidemiology outlining the Neuroblastoma scenario.
Neuroblastoma Epidemiology Segmentation The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Neuroblastoma thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.
Report Scope • The report covers detailed overview of Neuroblastoma explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan • The Neuroblastoma Report assesses the disease risk and burden and highlights the unmet needs • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population
Key strengths • 10 Year Forecast • 7MM Coverage • Total Cases in Neuroblastoma
Key assessments • Patient Segmentation in Neuroblastoma • Neuroblastoma Risk & Burden • Factors driving growth in a specific Neuroblastoma patient population
Our reports have been used by over 10K customers, including:
110 pages •
By Infiniti Research Limited
• Oct 2018
About Diffuse Large B-Cell Lymphoma DLBCL is a cancer of B-lymphocytes. It is the most common type of NHL among adults. It is an aggressive (fast-growing), complex, and difficult-to-treat form of NHL, which refers to a group of cancers of the lymphatic system. Technavio’s analysts forecast the Global DLBCL Therapeutics...
105 pages •
By Infiniti Research Limited
• Oct 2018
About Follicular Lymphoma Follicular lymphoma is a subtype of B-cell non-Hodgkin lymphoma (NHL). It is usually indolent (slow-growing) and the tumor cells grow as groups to form nodules. Symptoms of follicular lymphoma include enlarged lymph nodes, shortness of breath, fever, night sweats, and weight loss. Technavio’s...
United States Proton Therapy Market, Patients by 14 Cancer Types (Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer Cases (Up to Age 18), Gastrointestinal Tract Cancer, Urinary...
DelveInsight’s ‘Neuroblastoma (NB)- Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of HSV infections in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. Geography Covered • The United States • EU5...
Japan Proton Therapy Market, Patients by 10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others) Reimbursement Policies & Persons Treated at Centers Japan Proton Therapy Market has...
DelveInsight’s ‘Cutaneous T-cell lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of CTCL in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. The...